Tag Archives: high-density lipoprotein cholesterol
February 2011 Br J Cardiol 2011;18:37-45
Efficacy and safety of extended-release niacin/laropiprant in patients with type 2 diabetes mellitus
Alexandra MacLean, James M McKenney, Russell Scott, Eliot Brinton, Harold E Bays, Yale B Mitchel, John F Paolini, Hilde Giezek, Kristel Vandormael, Rae Ann Ruck, Kendra Gibson, Christine McCrary Sisk, Darbie L Maccubbin
An extended version of this paper is available in the downloadable PDFs (see right hand column) to registered users. Registration to the website is free of charge. Introduction Patients with type 2 diabetes mellitus (T2DM) have a two- to four-fold increased risk for cardiovascular disease (CVD) compared with individuals without T2DM.1 A dyslipidaemia pattern of increased levels of triglyceride (TG)-rich particles, and TG enrichment of high- and low-density lipoprotein (HDL and LDL) is common in patients with T2DM, affecting nearly all lipid and lipoprotein variables.2 As a result, dyslipidaemia in patients with T2DM is characterised by el
November 2006 Br J Cardiol 2006;13:411-8
Cost-effectiveness of adding prolonged-release nicotinic acid in statin-treated patients who achieve LDL cholesterol goals but remain at risk due to low HDL cholesterol: a UK-based economic evaluation
BJCardio editorial team
No content available
November 2003 Br J Cardiol 2003;10:462-8
Modified-release nicotinic acid for dyslipidaemia: novel formulation improves tolerability and optimises efficacy
Michael Schachter
No content available
For healthcare professionals only
